// startup autopsy
Genizon BioSciences
Quebec's genetic goldmine that couldn't be monetized
marketfitSlow Death
Years-long decline before final shutdown · Fatal mistake: Genizon built a scientifically compelling genomic database but failed to sign the major pharmaceutical partnerships needed to generate revenue before funding ran dry.
Key Events Timeline
FOUNDING
Genizon BioSciences founded in Montreal to leverage the unique genetic homogeneity of Quebec's founder population for drug discovery.
FUNDING
Genizon raises early-stage funding to build its genomic sequencing infrastructure and expand its population database.
PRODUCT LAUNCH
Company announces completion of large-scale Quebec population genomic database and begins marketing to pharmaceutical partners.
FUNDING
Final funding round closes amid growing concern that pharma partnerships are not materializing at the pace needed to sustain operations.
SHUTDOWN
Genizon BioSciences shuts down after exhausting funding without securing the commercial partnerships needed to achieve sustainability.